SQZ Biotechnologies Long Term Debt

SQZ Biotechnologies (SQZ) currently reports a long-term debt of $19M as of September 2023. That compares with $52M in the prior-year period — down 63.2% year over year. Use the charts on this page to explore SQZ Biotechnologies's long-term debt history and peer comparisons.

SQZ Biotechnologies's long-term debt decreased from $52M to $19M — a 63.2% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SQZ Biotechnologies reported $19M in long-term debt as of September 2023. That compares with $52M in the prior-year period — down 63.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SQZ Biotechnologies, and consider following SQZ for alerts when major investors trade the stock.

SQZ Biotechnologies is classified in the Healthcare sector. On long-term debt, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SQZ with unrelated industries.